Skip to main content
. 2020 May 1;21(9):3215. doi: 10.3390/ijms21093215
AOP Adverse outcome pathway
BPA Bisphenol A
DDT Dichlorodiphenyltrichloroethane
DEHP Bis(2-ethylhexyl) phthalate
DES Diethylstilbestrol
DHEA(S) Dehydroepiandrosterone(-sulfate)
EATS Estrogen-androgen-thyroid-steroidogenesis
EDC Endocrine disrupting chemical
FREIA “Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach”
FSH Follicle stimulating hormone
GnRH Gonadotropin-releasing hormone
GPER G-coupled protein oestrogen receptor
HP(A)G axis Hypothalamic-pituitary-(adrenal)-gonadal axis
IATA Integrated approach to testing and assessment
LH Luteinizing hormone
OECD Organisation for Economic Cooperation and Development
PCOS Polycystic ovary syndrome
POF Premature ovarian failure
POI Primary ovarian insufficiency
REACH Registration, Evaluation, Authorisation and restriction of CHemicals
TG Test guideline